Cargando…
Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever
Rift Valley Fever virus (RVFV) causes recurrent outbreaks of acute life-threatening human and livestock illness in Africa and the Arabian Peninsula. No licensed vaccines are currently available for humans and those widely used in livestock have major safety concerns. A ‘One Health’ vaccine developme...
Autores principales: | Warimwe, George M., Gesharisha, Joseph, Carr, B. Veronica, Otieno, Simeon, Otingah, Kennedy, Wright, Danny, Charleston, Bryan, Okoth, Edward, Elena, Lopez-Gil, Lorenzo, Gema, Ayman, El-Behiry, Alharbi, Naif K., Al-dubaib, Musaad A., Brun, Alejandro, Gilbert, Sarah C., Nene, Vishvanath, Hill, Adrian V. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742904/ https://www.ncbi.nlm.nih.gov/pubmed/26847478 http://dx.doi.org/10.1038/srep20617 |
Ejemplares similares
-
Potency of a thermostabilised chimpanzee adenovirus Rift Valley Fever vaccine in cattle
por: Dulal, Pawan, et al.
Publicado: (2016) -
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
por: Warimwe, George M, et al.
Publicado: (2013) -
Sociocultural and Economic Dimensions of Rift Valley Fever
por: Muga, Geoffrey Otieno, et al.
Publicado: (2015) -
Clinical manifestations of Rift Valley fever in humans: Systematic review and meta-analysis
por: Anywaine, Zacchaeus, et al.
Publicado: (2022) -
Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
por: Berg, Adam, et al.
Publicado: (2021)